Skip to content

Drug interactions

Ethosuximide + Letermovir

Severity: Moderate

Ethosuximide and Letermovir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir moderately inhibits CYP3A4 and may increase exposure to ethosuximide. This could lead to concentration-related adverse effects including sedation and gastrointestinal upset.

What this interaction means in plain words

Ethosuximide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ethosuximide belongs to Central Nervous System; Letermovir belongs to Anti Virals.

Evidence level: Low

Why it happens

CYP3A4 inhibition by letermovir reducing ethosuximide clearance.

What to do

Monitor clinical response and ethosuximide adverse effects; measure serum levels and reduce the dose if toxicity is suspected.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethosuximide and Letermovir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethosuximide with Letermovir?

MediHelp rates the interaction as moderate. Ethosuximide and Letermovir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letermovir moderately inhibits CYP3A4 and may increase exposure to ethosuximide. This could lead to concentration-related adverse effects including sedation and gastrointestinal upset.

How serious is the interaction between Ethosuximide and Letermovir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and ethosuximide adverse effects; measure serum levels and reduce the dose if toxicity is suspected.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in